Changing the paradigm: lobectomy for sporadic medullary thyroid cancer
This is the first European study that aims to evaluate the feasibility of lobectomy as first-line therapy for MTC based on the evaluation of thyroid US and serum Ct levels. These tools have been shown to have a good accuracy in detecting the affected lobe and strongly support the possibility to perform a more conservative surgery to treat RET-negative patients with suspicious MTC and nodular goiter.
Authors
- Gianlorenzo Dionigi (ORCID: https://orcid.org/0000-0003-0864-6087)
- Marina Lugaresi
- Claudia Moneta (ORCID: https://orcid.org/0000-0001-8728-7144)
- Giacomo Gazzano (ORCID: https://orcid.org/0000-0002-7416-4644)
- Laura Fugazzola (ORCID: https://orcid.org/0000-0001-5372-0982)
- Giulia Saruggia
Institutions
- University of Milan (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- European Thyroid Journal
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1530/etj-25-0040
- Citations
- 4
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.18